⚠️ Governments have continued to neglect the needs of patients with blood cancers such as leukaemia. This must change NOW.
Sign our open letter and join us in demanding better for those affected by this devastating disease: https://t.co/jJNET7kHTz
Thanks to you, our incredible supporters, this year we announced funding for 8 new research projects and 15 ongoing projects, all aiming to help bring us closer to saving and improving more lives 🧡
Take a look at some of our research highlights 👇
https://t.co/nmT9nlpTDF
Do you have experience in developing research strategies and leading long-term research funding streams? Have you led partnerships with research bodies and scientific panels?
If so, you could be our next Director of Research & Advocacy.
Apply now 👉 https://t.co/wzWaFOrc4A
🔬 Research alert! Could the virtual world of computer simulations help find the best treatment options for real patients?
Dr @SiFTW and his team’s innovative research showcases the power of using virtual patients to bring personalised medicine to lymphoma patients.
Find out how they are unlocking the potential of personalised medicine. https://t.co/E6kRZvz7aS
Can blood cancer be prevented? Consultant Haematologist, Sonia Wolf @freshblooddr found a way to identify people at high risk of a rare type of blood cancer & plans are in place to test a drug with potential to stop the disease developing.
Find out more: https://t.co/I5zfvSYFxw
We've awarded a project grant to Prof David Vetrie (@VetrieLab) to investigate the differences between #CML stem cells and guide the development of tests to predict treatment success.
This could revolutionise how treatment decisions are made.
https://t.co/od6Mqg50T3
Great comprehensive overview of who and when to transplant in patients with myelodysplastic syndromes (MDS) from @LeukUK John Goldman Fellow Dr Pramila Krishnamurthy @drpramilak#BSH2023
“My illness made me a better doctor and human being”
Such an insightful presentation from Dr Salim Shafeek about his experience of being a haematologist diagnosed with myeloma
#BSH2023
Now listening to the plenary discussion on teenage and young adult (TYA) cancer care at #BSH2023
🗣️ Good to listen to the views of Chloe, a young cancer patient with #ALL
Really eye-opening to hear from Holly, who was diagnosed with follicular lymphoma in 2021. She highlighted the importance of good patient communication & patient advocacy so eloquently. Thank you for sharing your story Holly #bsh2023
Great to be in Birmingham for the @BritSocHaem Annual Scientific Meeting. Looking forward to hearing about the latest blood cancer research developments over the next few days #bsh2023
Could you help develop and implement our ambitious research strategy? We’re looking for a Senior Research Interpretation Officer.
📍 Hybrid or remote location
◻️ 35 hours a week
◻️ £31,500 per annum
◻️ Application deadline: 20/02/23, 4pm
Apply: https://t.co/3i4Qm2lhnw
#SciComm
Big shout out to the very kind member of @nationalrailenq station staff who helped me & my 2 year old get home from Gatwick last night. She really went above and beyond to help when we were stranded for hours in the cold 🙏 🌟 #thekindnessofstrangers
A recent clinical trial at GOSH means 13-yr-old Alyssa is the first person in the world to receive base-edited therapy as part of her leukaemia treatment.
But what exactly is base editing? And how could it help more children like Alyssa? Our handy animation explains 👇
Talented #BloodCancer researcher, @VignirHelgason, was awarded a Leukaemia UK John Goldman Fellowship in 2015, for his research into chronic myeloid leukaemia (CML).
🧵...